Aperture Therapeutics
PrivateLast Round
Grant
Jun 15, 2026
Total Funding Raised
$1.09M
Company Overview
Aperture Therapeutics is a biotechnology company that develops oligonucleotide therapies for neurodegenerative diseases by leveraging human genetic resilience.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aperture Therapeutics Comparables
Compare Aperture Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Riboway Therapeutics | 78% | |
| NuCyRNA Therapeutics | 73% | |
| Trace Neuroscience | 68% | |
Aperture Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 15, 2026 | ||||
| Accelerator | Apr 7, 2025 | ||||
| Grant | Jul 2, 2024 |
Aperture Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongGame Ventures | Seed |
| age1 | Seed |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| Ferocity Capital | Seed |
| Conscience VC | Seed |
| Ono Venture Investment, Inc. | Accelerator |
| Mission BioCapital | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2025
Monthly visitors grew 417% MoM to 3.8K.
- Apr 7, 2025
$500K round led by Mission BioCapital.
Aperture Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aperture Therapeutics's valuation, stock price, and market status.